Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Adverum Biotechnologies, Inc.
| Metric | Adverum Biotechnologies, Inc. ADVMHealthcare |
|---|---|
| Quality Score | 28 / 100 |
| Revenue (latest) | $1M |
| Net income (latest) | −$27M |
| Operating margin | −2919.9% |
| Net margin | −2714.7% |
| Return on equity | −16.6% |
| Return on assets | −10.8% |
| Return on capital (ROCE) | −12.5% |
| Debt / equity | 0.53× |
| Revenue growth (YoY) | −72.2% |
| Altman Z″ (distress) | -6.56 |
| Accruals / assets | 26.1% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.